Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance

Go back to Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance

Xylem (XYL) PT Raised to $162 at RBC Capital

May 3, 2024 6:54 AM EDT

RBC Capital analyst Deane Dray raised the price target on Xylem (NYSE: XYL) to $162.00 (from $157.00) while maintaining a Outperform rating.

The analyst comments "Outperform-rated Xylem reported a clean 1Q24 6.5c/7% operating beat vs. our estimates, driven by upside at M&CS and WSS.... More